Annual report pursuant to Section 13 and 15(d)


11 Months Ended
Dec. 31, 2021
USD ($)
Cash Flows from Operating Activities:  
Net income $ 3,732,702
Adjustments to reconcile net income to net cash used in operating activities:  
Interest earned on marketable securities held in Trust Account (6,512)
Change in fair value of warrant liabilities (4,907,984)
Offering costs allocated to warrants 329,619
Changes in operating assets and liabilities:  
Prepaid expenses (599,911)
Accrued expenses 478,611
Net cash used in operating activities (973,475)
Cash Flows from Investing Activities:  
Investment of cash in Trust Account (172,500,000)
Net cash used in investing activities (172,500,000)
Cash Flows from Financing Activities:  
Proceeds from issuance of Class B common stock to Sponsor 25,000
Proceeds from sale of Units, net of underwriting discounts paid 169,050,000
Proceeds from sale of Private Placements Warrants 5,700,000
Proceeds from promissory note - related party 46,975
Repayment of promissory note - related party (46,975)
Payment of offering costs (460,299)
Net cash provided by financing activities 174,314,701
Net Change in Cash 841,226
Cash - Beginning of period 0
Cash - End of period 841,226
Non-Cash investing and financing activities:  
Initial value of common stock subject to possible redemption 172,500,000
Deferred underwriting fee payable 6,037,500
Initial measurement of public warrants and private placement warrants 9,842,500
Re-measurement of Common Stock subject to redemption $ 14,909,680